Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation

Anuj Mahindra, Brian Bolwell, Ronald Sobecks, Lisa Rybicki, Brad Pohlman, Robert Dean, Steve Andresen, John Sweetenham, Matt Kalaycio, Edward Copelan

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Summary Elevated pretransplant serum ferritin levels have been associated with an increased incidence of morbidity and mortality after allogeneic haematopoietic stem cell transplantation (HCT). We studied 222 patients who underwent myeloablative allogeneic HCT in whom pretransplantation serum ferritin levels were available. Pretransplantation ferritin > 1910 μg/l was associated with lower overall survival (P = 0·003), lower relapse-free survival (P = 0·003), decreased chronic graft-versus-host disease (GVHD) (P = 0·019) and increased non-relapse mortality (NRM) (P = 0·042). Similar results were obtained when pretransplantation ferritin was analysed as a continuous variable and by quartiles. Our results indicate that an elevated pretransplant ferritin level adversely impacts transplantation outcomes. The adverse impact of elevated ferritin on NRM and survival was despite its association with lower incidences of acute and chronic GVHD, which are major causes of NRM. The association of ferritin with iron overload and its influence on HCT outcomes requires further prospective validation.

Original languageEnglish (US)
Pages (from-to)310-316
Number of pages7
JournalBritish Journal of Haematology
Volume146
Issue number3
DOIs
StatePublished - Aug 1 2009
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Ferritins
Survival
Incidence
Mortality
Iron Overload
Serum
Transplantation
Morbidity
Recurrence

Keywords

  • Allogeneic transplantation
  • Graft-versus-host disease
  • Iron overload
  • Non-relapse mortality
  • Pretransplantation ferritin

ASJC Scopus subject areas

  • Hematology

Cite this

Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. / Mahindra, Anuj; Bolwell, Brian; Sobecks, Ronald; Rybicki, Lisa; Pohlman, Brad; Dean, Robert; Andresen, Steve; Sweetenham, John; Kalaycio, Matt; Copelan, Edward.

In: British Journal of Haematology, Vol. 146, No. 3, 01.08.2009, p. 310-316.

Research output: Contribution to journalArticle

Mahindra, Anuj ; Bolwell, Brian ; Sobecks, Ronald ; Rybicki, Lisa ; Pohlman, Brad ; Dean, Robert ; Andresen, Steve ; Sweetenham, John ; Kalaycio, Matt ; Copelan, Edward. / Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. In: British Journal of Haematology. 2009 ; Vol. 146, No. 3. pp. 310-316.
@article{381efd8b1fdb4c24a2dc577e800b157f,
title = "Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation",
abstract = "Summary Elevated pretransplant serum ferritin levels have been associated with an increased incidence of morbidity and mortality after allogeneic haematopoietic stem cell transplantation (HCT). We studied 222 patients who underwent myeloablative allogeneic HCT in whom pretransplantation serum ferritin levels were available. Pretransplantation ferritin > 1910 μg/l was associated with lower overall survival (P = 0·003), lower relapse-free survival (P = 0·003), decreased chronic graft-versus-host disease (GVHD) (P = 0·019) and increased non-relapse mortality (NRM) (P = 0·042). Similar results were obtained when pretransplantation ferritin was analysed as a continuous variable and by quartiles. Our results indicate that an elevated pretransplant ferritin level adversely impacts transplantation outcomes. The adverse impact of elevated ferritin on NRM and survival was despite its association with lower incidences of acute and chronic GVHD, which are major causes of NRM. The association of ferritin with iron overload and its influence on HCT outcomes requires further prospective validation.",
keywords = "Allogeneic transplantation, Graft-versus-host disease, Iron overload, Non-relapse mortality, Pretransplantation ferritin",
author = "Anuj Mahindra and Brian Bolwell and Ronald Sobecks and Lisa Rybicki and Brad Pohlman and Robert Dean and Steve Andresen and John Sweetenham and Matt Kalaycio and Edward Copelan",
year = "2009",
month = "8",
day = "1",
doi = "10.1111/j.1365-2141.2009.07774.x",
language = "English (US)",
volume = "146",
pages = "310--316",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation

AU - Mahindra, Anuj

AU - Bolwell, Brian

AU - Sobecks, Ronald

AU - Rybicki, Lisa

AU - Pohlman, Brad

AU - Dean, Robert

AU - Andresen, Steve

AU - Sweetenham, John

AU - Kalaycio, Matt

AU - Copelan, Edward

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Summary Elevated pretransplant serum ferritin levels have been associated with an increased incidence of morbidity and mortality after allogeneic haematopoietic stem cell transplantation (HCT). We studied 222 patients who underwent myeloablative allogeneic HCT in whom pretransplantation serum ferritin levels were available. Pretransplantation ferritin > 1910 μg/l was associated with lower overall survival (P = 0·003), lower relapse-free survival (P = 0·003), decreased chronic graft-versus-host disease (GVHD) (P = 0·019) and increased non-relapse mortality (NRM) (P = 0·042). Similar results were obtained when pretransplantation ferritin was analysed as a continuous variable and by quartiles. Our results indicate that an elevated pretransplant ferritin level adversely impacts transplantation outcomes. The adverse impact of elevated ferritin on NRM and survival was despite its association with lower incidences of acute and chronic GVHD, which are major causes of NRM. The association of ferritin with iron overload and its influence on HCT outcomes requires further prospective validation.

AB - Summary Elevated pretransplant serum ferritin levels have been associated with an increased incidence of morbidity and mortality after allogeneic haematopoietic stem cell transplantation (HCT). We studied 222 patients who underwent myeloablative allogeneic HCT in whom pretransplantation serum ferritin levels were available. Pretransplantation ferritin > 1910 μg/l was associated with lower overall survival (P = 0·003), lower relapse-free survival (P = 0·003), decreased chronic graft-versus-host disease (GVHD) (P = 0·019) and increased non-relapse mortality (NRM) (P = 0·042). Similar results were obtained when pretransplantation ferritin was analysed as a continuous variable and by quartiles. Our results indicate that an elevated pretransplant ferritin level adversely impacts transplantation outcomes. The adverse impact of elevated ferritin on NRM and survival was despite its association with lower incidences of acute and chronic GVHD, which are major causes of NRM. The association of ferritin with iron overload and its influence on HCT outcomes requires further prospective validation.

KW - Allogeneic transplantation

KW - Graft-versus-host disease

KW - Iron overload

KW - Non-relapse mortality

KW - Pretransplantation ferritin

UR - http://www.scopus.com/inward/record.url?scp=67650478252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650478252&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2009.07774.x

DO - 10.1111/j.1365-2141.2009.07774.x

M3 - Article

C2 - 19508292

AN - SCOPUS:67650478252

VL - 146

SP - 310

EP - 316

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -